KEFLET Drug Patent Profile
✉ Email this page to a colleague
When do Keflet patents expire, and what generic alternatives are available?
Keflet is a drug marketed by Lilly and is included in two NDAs.
The generic ingredient in KEFLET is cephalexin. There are twenty-nine drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the cephalexin profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Keflet
A generic version of KEFLET was approved as cephalexin by TEVA on February 13th, 1987.
Summary for KEFLET
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 68 |
Patent Applications: | 4,861 |
Formulation / Manufacturing: | see details |
DailyMed Link: | KEFLET at DailyMed |
US Patents and Regulatory Information for KEFLET
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lilly | KEFLET | cephalexin | TABLET;ORAL | 050440-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | KEFLET | cephalexin | TABLET;ORAL | 062745-002 | Dec 1, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | KEFLET | cephalexin | TABLET;ORAL | 062745-001 | Dec 1, 1986 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lilly | KEFLET | cephalexin | TABLET;ORAL | 050440-003 | Feb 26, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |